Efficacy of tolvaptan added to furosemide in heart failure patients with advanced kidney dysfunction: a pharmacokinetic and pharmacodynamic study. 2015.03.4 Tweet Share 雑誌:Clin Pharmacokinet. 2015 Mar;54(3):273-84. 著者:Kida K, Shibagaki Y, Tominaga N, Matsumoto N, Akashi YJ, Miyake F, Kimura K. Tweet Share Effects of additive tolvaptan vs. increa…前の記事 Combined disease with pulmonary arterial…次の記事
雑誌:Clin Pharmacokinet. 2015 Mar;54(3):273-84. 著者:Kida K, Shibagaki Y, Tominaga N, Matsumoto N, Akashi YJ, Miyake F, Kimura K.